rs140727644
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_021254.4(CFAP298):c.422A>G(p.Asp141Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000265 in 1,613,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_021254.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CFAP298 | NM_021254.4 | c.422A>G | p.Asp141Gly | missense_variant | Exon 4 of 7 | ENST00000290155.8 | NP_067077.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152116Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000195 AC: 49AN: 251490 AF XY: 0.000213 show subpopulations
GnomAD4 exome AF: 0.000274 AC: 400AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.000259 AC XY: 188AN XY: 727234 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000184 AC: 28AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74318 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia 26 Uncertain:1
The CFAP298 c.422A>G; p.Asp141Gly variant (rs140727644) is reported in the literature in an individual affected with primary ciliary dyskinesia, although a second variant was not identified (Austin-Tse 2013). This variant is found in the non-Finnish European population with an allele frequency of 0.036% (47/129,186 alleles) in the Genome Aggregation Database (v2.1.1). Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.194). Functional analysis of the variant suggests moderately reduced ability to rescue cilia motility compared to wildtype CFAP298 in a zebrafish knockdown model (Austin-Tse 2013); however, the physiological relevance of this difference remains unclear. Due to limited information, the clinical significance of this variant is uncertain at this time. References: Austin-Tse C et al. Zebrafish Ciliopathy Screen Plus Human Mutational Analysis Identifies C21orf59 and CCDC65 Defects as Causing Primary Ciliary Dyskinesia. Am J Hum Genet. 2013 Oct 3;93(4):672-86. PMID: 24094744.
not provided Uncertain:1
This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 141 of the C21orf59 protein (p.Asp141Gly). This variant is present in population databases (rs140727644, gnomAD 0.04%). This missense change has been observed in individual(s) with primary ciliary dyskinesia (PMID: 24094744). ClinVar contains an entry for this variant (Variation ID: 525246). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects C21orf59 function (PMID: 24094744). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at